Anavex Life Sciences (AVXL) Tops Q1 EPS by 6c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Glass House Brands Inc. (GLAS) reported Q2 Revenue
• Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance